Exchange: NASDAQ·Updated 07:40 PM EDT
VVOS logo

VVOS Vivos Therapeutics Inc

$0.162
$0.0128
(7.27%)
Today
Closed $0.1632
$0.0012
(0.73%)
After Hours
EarningsNov 16
Mkt Cap$5.49M
Vol1.67M

About VVOS

Vivos Therapeutics, Inc. is a medical technology company which engages in the development and commercialization of treatment alternatives for patients with sleep disordered breathing (SDB). Its solutions are also offered for patients with mild-to-moderate obstructive sleep apnea (OSA). The company was founded by Gurdev Dave Singh, Susan McCullough, RaeAnn Byrnes, Todd Huntsman, and R. Kirk Huntsman on July 7, 2016 and is headquartered in Littleton, CO.
32

Bearish Sentiment

How do you feel about VVOS?

TeamBullish
One mistake I made when I first started trading was setting my risk around a fixed percentage. I would tell myself, “If this trade drops 5% or 10%, I’m out,” without considering the actual structure of the setup. Never approach risk that way. Your entry, profit targets, and stop loss should be built around the unique stock in front of you, including its support, supply, liquidity, volume, and the price level where demand and buying pressure begin to weaken. Every setup behaves differently, so a percentage alone cannot tell you when the original trade thesis is invalid. True risk management means aligning yourself with the market conditions, identifying the level that proves you wrong, and letting the data determine your exit before you ever enter the trade. $VVOS $CLGN $AEHL $NCRA $GPRO
26
ACInvestorBlog
$VVOS green .... can run hard if volume comes in... next week conference could fuel a big bounce on the name.
12
Butterflies5
$VVOS TO ALL: Streeterville Capital, LLC filed an amended schedule 13g with the SEC TODAY confirming that their ownership of 1,812,031 shares representing 9.3% ownership stake in VVOS ( the dilutive overhang on the stock ) has been REDUCED to a mere 122,963 shares Streeterville's emense Debt to Equity position and conversion thereof was thee main threat to shareholders. Today's 13g filing now clarifies the fact that they have indeed LIQUIDATED all but 122,963 shares of their 1.81 million share holdings So there you have it, in black & white. The dilution appears to have been completely absorbed by the street (whales,institutions and retail) I repeat, because streeterville holds only 122,000 shares effective today, the vast majority of their initial convertible debt to equity position has already been flushed into the common stock pool. Proof? sec.gov/Archives/edgar/data/1716166/000185141626000030/xslSCHEDULE_13G_X02/primary_doc.xml https://share.google/VC6S7BkiMfl2mfWva
3
2
Butterflies5
$VVOS TO ALL: 1. Effective yesterday, via Form 13-G filed with the SEC, Streeterville Capital has completed their toxic dilution of 1.8M shares into the open market 2. Vivos has raised the necessary $2.6 million dollars they needed to meet NASDAQ minimum shareholder equity 3. Vivos Therapeutics is scheduled to present at the 2026 Moody Capital Solutions disruptive growth and Life Sciences conference next wednesday, September 9th 2026 at 8:45 a.m. The initial presentation will be immediately followed by a question and answer session. Executive management will remain available for one-on-one meetings with institutional investors throughout the duration of the two-day conference which spans September 9th through the 10th
9
GamblerDan
$VVOS What exactly have YOU uncovered? You’re a new bag holder likely with a very low average still thinking about a quick flip for profit. Many of us been with this stock for years and just absolutely fed up with Kuntsman not delivering. Over the years we get new baggies show up and gone quickly after the slightest rise in price. Forgive us if our enthusiasm has been lacking. FYI most here are well informed with all the filings..
9
stockpicker12e
$VVOS They have a lot of time to get this stock price over a dollar. I don't think they will need a reverse split. It can happen in one day! This company is for real!
9
Butterflies5
$VVOS Revenue grew strongly, rising to $10.3M for the first half of 2026 from $6.8M a year earlier, driven by expanded sleep testing and treatment center services. The company raised $9.3M in cash from financing activities in the first half of 2026, including PIPE offerings, warrant exercises and ATM sales, partially offsetting operating cash burn. Vivos Therapeutics announced that founder and CEO R. Kirk Huntsman will present at the 2026 Moody Capital Solutions Disruptive Growth & Life Sciences Conference at The Westin New York Grand Central in New York City on September 9, 2026, at 8:45 a.m. Eastern Time. Management will also hold a Q&A session and be available for one-on-one meetings with institutional investors during the conference.
1
6
jeffthechef
$VVOS was a buy around $8 a little over a year ago! Conference is coming up. I’m loading up at this price. Tell all your friends. I am too.
8
kemsma62
$VVOS According my IBKR: Still 0 shares to borrow! 👀 Borrow rate creeping up to 25%! 🔥👇 According FINTEL: At least 98.54M (59%) were reported as short sales incl. Dark in the FINRA off-exchange data tracked by Fintel. And importantly, Fintel itself warns that its aggregate figures do not cover every trading venue, so the 167M/98.5M figures are not the complete market-wide totals. (+500M yesterday) Give us some positivity! 👍🤞
1
5
johh22
$VVOS H SCUMBAG ACInvestorblog was pumping this and PSQH and they are both down 90 pct plus . I hate that cocky pos . I would love to beat the fuck out of that scumbag. I wish he were man enough to sign a release to not press charges . I hate that scumbag pos .
4
Stockwinner13
$VVOS after yesterday’s presentation there has to be a new partner investor if not more than one. My God. They have a ln incredible product and service that saves lives! Tackles several common chronic health problems.
6
kemsma62
$VVOS Just went from easy-to-borrow (5-8%) to 122% fee at 0 shares available at IBKR. First real “hard-to-borrow” (HTB) signal in a long time. Shorts now paying up big and can’t easily add. With the sleep center momentum building, this setup can get spicy fast. 👀👇
6
john_diddly
$VVOS We’ve already all but confirmed that the first tranche of the Streeterville deal was triggered earlier in August when they filed a 13G. The required equity financing was obtained via the PIPE with V-Co 4 and Bigger Capital and subsequent ATM sales. I’m sure the company was desperate to get the balance of the exchange with Streeterville completed by yesterday and prop up their equity ever so slightly more. The most pressing threat is certainly the NASDAQ minimum equity - if they get delisted they lose the ability to dump on retail and keep their paychecks coming in. Not sure if all the funny business lately is related to this or not. Oh, and FIRE HUNTSMAN FFS.
6
lilnormy
$VVOS The Lord looked down on the many suffering bagholders of vvos and had pity on them. The Lord then commanded that there be one more run before market close and he saw that it was good.
1
3
Nordan00
$VVOS CEO presenting today at 8:45 EST at the Moody Capital Solutions Disruptive Growth and Life Sciences Conference in NYC.
5
Creyedr
$VVOS shorts are going to have a problem here...not enough shares out there, please don't lend them out.
5
AndyBiltz1
$VVOS for what? A reverse split that dilutes everyone? No thanks! This never even sees .25 again.
1
2
ka1954
$VVOS what an amazing story fuckers !!! ur stock has been hijacked by the shorts and u still believe ur own shit. Why these idiots couldn't hire some traders to pump their stock 200%+ to kill the stock like other stock do "Given the significant and positive trends that our business has been taking over the past few months, this is a perfect time to get our message out to the financial markets," said Mr. Huntsman. "We look forward to visiting with investors and telling our amazing story."
1
2
GamblerDan
$VVOS I see plenty of newbies here falling for the same presentation speech Kuntsmans been spewing for many years now almost verbatim. Go back and listen to interviews from years ago. The real problem here is EXECUTION EXECUTION EXECUTION!!
4
lilnormy
$VVOS The CEO did a great job at the conference. I learned a lot about the device and how it cures the problem in less than a year. Huge market too.
4

Advertisement|Remove ads.